Hybio Pharmaceutical Co.,Ltd. Posted 35 Million Yuan Net Loss in First Half of 2023

Hybio Pharmaceutical Co.,Ltd. (深圳翰宇药业股份有限公司) (300199.SZ) reported a net loss of 35 million yuan in the first half of 2023, narrowing 64.8% year-on-year.

Meanwhile, the company posted 325.3 million yuan in revenue, down 8.8% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 63.2%.